634 results on '"Ertekin-Taner, Nilufer"'
Search Results
52. Gene‐based polygenic score analysis identifies novel immune genes with deleterious variants that associate with Alzheimer’s disease
53. Association of DNA methylation from the temporal cortex and cerebellum with AD‐related neuropathology and biochemistry
54. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans
55. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease
56. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's Disease related proteins
57. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease.
58. Hemispheric Cortical Atrophy ipsilateral to Carotid Stenosis (N5.001)
59. Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease
60. Risk factors for severe COVID-19 differ by age: a retrospective study of hospitalized adults
61. Single Nuclei Transcriptome Reveals Perturbed Brain Vascular Molecules in Alzheimer's Disease
62. An examination of atypical primary progressive aphasia variants
63. Cancer survivors have a lower frequency of dementia in the 95+ oldest‐old
64. Understanding the transcriptional (dys)regulation in progressive supranuclear palsy
65. Plasma transcript profiling identifies significant differentially expressed genes and expression of quantitative trait loci in African Americans
66. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
67. Assessment of the genetic variance of late-onset Alzheimer's disease
68. Transcriptional landscape of human microglia reveals robust gene expression signatures that implicates age, sex and APOE-related immunometabolic pathway perturbations
69. Abstract 8: Retinopathy is Associated With Stroke, Dementia, and Mortality
70. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)
71. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer’s Disease Research Center (ADRC)
72. Leveraging selective hippocampal vulnerability among Alzheimer’s disease subtypes reveals a novel tau binding partner SERPINA5
73. Investigating gene expression changes underlying selective hippocampal vulnerability in Alzheimer’s disease using a translational neuropathology approach
74. A consensus proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
75. Characterizing the cognitive phenotype of Parkinson’s disease
76. Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ε4,and the Risk of Late-Onset Alzheimer Disease in African Americans
77. Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types
78. MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
79. Analysis of Human Brain Tissue Transcriptome Reveals Risk Genes and Altered Molecular Pathways in Glioma-related Seizures (1044)
80. Intensive vs. Standard Blood Pressure Control in White Matter Disease Progression: Systematic Review and Meta-analysis (5255)
81. Longitudinal Amyloid-β PET in Atypical Alzheimer’s Disease and Frontotemporal Lobar Degeneration
82. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease
83. Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes
84. Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease.
85. Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease Pedigrees
86. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
87. GENE-48. ANALYSIS OF HUMAN BRAIN TISSUE TRANSCRIPTOME TO IDENTIFY RISK GENES AND ALTERED MOLECULAR PATHWAYS IN GLIOMA-RELATED SEIZURES
88. A Consensus Proteomic Analysis of Alzheimer’s Disease Brain and Cerebrospinal Fluid Reveals Early Changes in Energy Metabolism Associated with Microglia and Astrocyte Activation
89. Evaluation of Associations of Alzheimer’s Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures
90. P2-294: RETROSPECTIVE REVIEW OF CLINICAL FEATURES OF ABCA7 LOSS-OF-FUNCTION MUTATION CARRIERS IN LATE-ONSET ALZHEIMER'S DISEASE
91. O2-10-01: STOP-GAIN AND NON-SYNONYMOUS VARIANTS IN NOVEL GENES OF AN IMMUNE CO-REGULATORY NETWORK SHOW STRONG ASSOCIATION WITH ALZHEIMER'S DISEASE
92. O4-10-01: CHARACTERIZING CELL TYPE-SPECIFIC EXPRESSION SIGNATURES IN BRAIN USING SINGLE CELL RNA SEQUENCING
93. P4-330: LONGITUDINAL BEHAVIOR OF BETA-AMYLOID IN NEURODEGENERATIVE DEMENTIAS
94. P2-427: THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS
95. O5‐02‐04: INTEGRATIVE GENOMIC PROFILING TO IDENTIFY GENES AND PATHWAYS ASSOCIATED WITH VASCULAR RISK IN AD
96. P4-103: CELL-TYPE SPECIFIC MECHANISTIC AND DIRECTIONAL TRANSCRIPTIONAL REGULATORY NETWORKS IN ALZHEIMER'S DISEASE
97. Molecular estimation of neurodegeneration pseudotime in older brains
98. Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight
99. Systematic analysis of dark and camouflaged genes: disease-relevant genes hiding in plain sight
100. Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.